Lezack Adam 4
4 · Beta Bionics, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Lezack Adam
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-31+9,137→ 9,137 totalExercise: $5.10Exp: 2033-12-11→ Common Stock (9,137 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest in 36 equal monthly installments measured from December 12, 2023.
- [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.